Baxter International Stock News

Related Stocks: EW , ISEE , BLU , EGRX , CYCC , BAX , SGEN , MRK , SKIN , SRPT , LEGN , JAZZ , PTGX , JNJ , CI , ALDX , PFE ,

Baxter's (BAX) strategic investment to help expand the manufacturing footprint of BPS and ensure improvement in products.

Related Stocks: LDUR , DWM , TSLA , ECOR , BAX , R , TXMD ,

Related Stocks: VIG , GNRC , HCAT , PANW , BAX , CHRW , TWLO , ORLY , PAYC , FCX , IEMG , CI , WBA , CAT , YETI ,

Equities research analysts predict that Baxter International Inc. (NYSE:BAX) will report $1.02 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have provided estimates for Baxter Internationals earnings, with the lowest EPS estimate coming in at $1.01 and the highest estimate coming in at $1.03. Baxter International posted earnings []

Key Players Covered in the Home Infusion Therapy Market Research Report are Optum, Inc., Infusystem, Option Care Health Inc., Moog Inc., CareCentrix, Inc., B. Braun Melsungen AG, Lincare Holdings Inc., Baxter, Promptcare, BriovaRx Infusion Services and other key market players. Key Players Covered in the Home Infusion Therapy Market Research Report are Optum, Inc., Infusystem, Option Care Health Inc., Moog Inc., CareCentrix, Inc., B. Braun Melsungen AG, Lincare Holdings Inc., Baxter, Promptcare, BriovaRx Infusion Services and other key market players.

Baxter International Inc (NYSE: BAX) posted Q3 revenue of $3.23 billion, in line with the consensus, up 9% on a reported basis, 7% on a constant currency basis, and 6% on an operational basis. Adjus

Baxter's (BAX) third-quarter results reflect robust performance across all its business units.

Baxter (BAX) delivered earnings and revenue surprises of 8.51% and 0.05%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Baxter's (BAX) third-quarter results are likely to reflect growth in its Acute Therapies business.

Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Credit Suisse 30th Annual Virtual Healthcare Conference on Monday

We believe that Baxter stock is a good buying opportunity at the present time. BAX stock trades near $81 currently and it is, in fact, down 13% from its pre-Covid high of $93 in February 2020 – just

MedTech stocks like Boston Scientific (BSX), Catalent (CTLT) and Baxter (BAX) are likely to solidify businesses on the back of impressive M&As.

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its third-quarter 2021 financial results on Th